期刊
MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
卷 31, 期 5, 页码 962-968出版社
ELSEVIER
DOI: 10.1016/j.msec.2011.02.017
关键词
Microparticles; Carvedilol; PCL; PHBV; Controlled release
资金
- Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)
Polymeric microparticles containing carvedilol (CRV) were obtained successfully using a simple emulsion/organic evaporating method. Three different formulations were developed using poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) and polycaprolactone (PCL) as polymers: the resulting samples were submitted to physical-chemical characterization and in vivo evaluation. The physical-chemical analysis indicated that the PHBV promoted a porous aspect in the microparticle's surface, while PCL a smooth aspect. The PCL-CRV microparticles showed a higher loading efficiency and a longer drug release time, being selected for in vivo evaluation. The in vivo assays indicated that PCL-CRV polymeric microparticles has a pharmacological antihypertensive effect for a longer period of time, representing a good alternative to improved the life quality of the patient that uses this drug. (C) 2011 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据